Peripheral blood mononuclear cell clinical trials
How each study uses peripheral blood mononuclear cell is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the peripheral blood mononuclear cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Peripheral blood mononuclear cell
- 1
Studies by the year they started
3 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Mahidol University (1) · Nadezhda Women's Health Hospital (1) · Assistance Publique Hopitaux De Marseille (1)
Studies
Open first, then newest update. How each study uses peripheral blood mononuclear cell is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells PopulationsRecruitingNot applicableNadezhda Women's Health HospitalNCT05421364Written as Intrauterine administration of autologous peripheral blood mononuclear cells (PBMC)
- Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear CellsCompletedPhase 3Mahidol UniversityNCT01833585Written as Peripheral blood mononuclear cell
- Study to Evaluate the Value of the Follow-up of CALCIneurin Activity to MOdulate Calcineurin Inhibitors-induced Immunosuppression in Lung TransplantationStatus unknownNot applicableAssistance Publique Hopitaux De MarseilleNCT02897895Written as Calcineurin activity (CN-a) in peripheral blood mononuclear cells (PBMCs)